GlassScriptPhysician profile
Joseph O Converse
NPI 1669485330
$1,061.89
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $27.55 · 2021: $344 · 2022: $310 · 2023: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $430.02 | 2019-2023 | Rinvoq, Skyrizi, Viberzi |
| E.R. Squibb & Sons, L.L.C. | $141.16 | 2022 | |
| Gilead Sciences, INC. | $125.90 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.71 | 2021-2023 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $62.91 | 2021-2023 | Gattex |
| Merck Sharp & Dohme LLC | $44.69 | 2022-2023 | Dificid |
| Ironwood Pharmaceuticals, INC | $27.25 | 2020-2021 | |
| Olympus America INC. | $22.20 | 2019 | |
| Celgene Corporation | $21.65 | 2023 | Zeposia |
| Axonics, INC. | $20.64 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $19.41 | 2022 | |
| Ardelyx, INC. | $19.29 | 2023 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $15.78 | 2023 | Ocaliva |
| Abbott Laboratories | $15.46 | 2019 | |
| Pfizer INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Converse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.